Cann Group is a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and approved export markets. Cann has established research, cultivation and GMP manufacturing facilities in Bundoora, in northern Melbourne, and a state-of-the-art large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group’s leading position in plant genetics, breeding, extraction, analysis and production techniques supports its objective to supply high quality, safe medicinal cannabis for a range of diseases and medical conditions. Incorporated in the Company's brand portfolio is its proprietary Satipharm delivery system for cannabinoids. Botanitech is a brand created by Cann and boasts a diverse, affordable and high-quality product range.


ASX Announcements

More Announcements

Annual Report 2023

DownloadOpens in new window